Clinical Trials Directory

Trials / Completed

CompletedNCT02867319

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention · Academic / Other
Sex
All
Age
2 Years – 50 Years
Healthy volunteers
Accepted

Summary

This phase I clinical study evaluates the safety of ACYW135 meningococcal polysaccharide vaccine in population aged 2-6, 7-17, 18-50 years old by the method of both passive and active surveillance.

Conditions

Interventions

TypeNameDescription
BIOLOGICALA dose of ACYW135 meningococcal polysaccharide vaccineA dose of ACYW135 meningococcal polysaccharide vaccine will be given in certain arm.

Timeline

Start date
2016-03-01
Primary completion
2016-07-01
First posted
2016-08-15
Last updated
2016-08-16

Source: ClinicalTrials.gov record NCT02867319. Inclusion in this directory is not an endorsement.

Safety Study of ACYW135 Meningococcal Polysaccharide Vaccine Aged 2-50 Years Old (NCT02867319) · Clinical Trials Directory